Skip to content
Home/Companies/Healthcare/Urania Therapeutics
UT

Urania Therapeutics

Healthcare·France·Active·7yr hold

Urania Therapeutics is a healthcare company, headquartered in France.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns Urania Therapeutics?

Urania Therapeutics is currently owned by AdBio Partners through AFB Seed-Fund (2017 vintage), since 2019. Across its history, Urania Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

AdBio Partners
Most recent investor
AdBio Partners
AFB Seed-Fund · 2017 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by AdBio Partners and Capital Grand Est since 2019.
Co-invest · 2 holders · 2019 · present
AdBio Partners
AdBio PartnersActive
2019 · present · AFB Seed-Fund · 2017 · VC
MOIC
–
Capital Grand Est
Capital Grand EstActive
2020 · present · Cap Innov'Est 1 · 2014 · VC
MOIC
–

More from AFB Seed-Fund

Other portfolio companies in the same fund.

Alderaan Biotechnology
Active
HealthcareFrance· 2020
ARTHEx Biotech
Active
HealthcareSpain· 2020
GAMUT Therapeutics
Exited 2021
BiotechFrance· 2020
to
Kalsiom
Active
HealthcareFrance· 2020
Wellium
Active
HealthcareFrance· 2020
Agomab Therapeutics
Exited 2026
HealthcareBelgium· 2019
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings